Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-06FDA Approved: PROPRANOLOL HYDROCHLORIDE — Original Application (Lannett Company, Inc.)
FDA approved the original application for propranolol hydrochloride from Lannett Company, Inc., enabling a generic version to be marketed.
-
FDA approval · 2020-01-03FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for divalproex sodium from Upsher-Smith Laboratories, indicating a regulatory action related to …
-
FDA approval · 2019-12-23FDA Approved: UBRELVY — Original Application (Allergan, Inc.)
The FDA approved UBRELVY (ubrogepant) from Allergan, Inc. as the original application for the acute treatment of migraine in adults. The app…
-
FDA approval · 2019-12-20FDA Approved: ONZETRA XSAIL — Supplemental Application (Currax Pharmaceuticals LLC)
The FDA approved a supplemental application for ONZETRA XSAIL (sumatriptan succinate) filed by Currax Pharmaceuticals LLC.
-
FDA approval · 2019-12-20FDA Approved: ZOLMITRIPTAN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Zolmitriptan from Rising Pharma Holdings, Inc., supporting changes to the generic’s labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-12-17FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Lannett Company, Inc.)
FDA approved an original ANDA for a generic Butalbital/acetaminophen/caffeine combination (butalbital, acetaminophen and caffeine) by Lannet…
-
FDA approval · 2019-12-06FDA Approved: ZOLMITRIPTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Zolmitriptan from Alembic Pharmaceuticals Limited, indicating an updated or additional approval …
-
FDA approval · 2019-12-05FDA Approved: EMGALITY — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Emgality (galcanezumab) from Eli Lilly and Company.
-
FDA approval · 2019-12-03FDA Approved: ZOLMITRIPTAN — Supplemental Application (Ajanta Pharma USA Inc.)
FDA lists a supplemental approval for zolmitriptan from Ajanta Pharma USA Inc. under an ANDA, indicating the approval of a supplemental appl…
-
FDA approval · 2019-11-29FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Rizatriptan Benzoate as a generic version under ANDA204339.
-
FDA approval · 2019-11-29FDA Approved: RIZATRIPTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Rizatriptan submitted by Macleods Pharmaceuticals Limited.
-
FDA approval · 2019-11-29FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Rizatriptan Benzoate by Macleods Pharmaceuticals Limited. The action adds regulatory approval fo…
-
FDA approval · 2019-11-29FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application from Unichem Pharmaceuticals (USA), Inc. for Rizatriptan Benzoate, authorizing the marketing of a ge…
-
FDA approval · 2019-11-22FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application to introduce Depakote Sprinkles (divalproex sodium) from AbbVie, expanding the drug's dosage form op…
-
FDA approval · 2019-10-29FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Sumatriptan Succinate from Sun Pharmaceutical Industries, Inc., reflecting an approval of a …
-
FDA approval · 2019-10-24FDA Approved: FROVATRIPTAN SUCCINATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for frovatriptan succinate from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2019-10-18FDA Approved: DIVALPROEX SODIUM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' divalproex sodium as a generic product under Original Application (ANDA 209286).
-
FDA approval · 2019-10-11FDA Approved: REYVOW — Original Application (Eli Lilly and Company)
FDA granted original approval for REYVOW (lasmiditan) by Eli Lilly for the acute treatment of migraine.
-
FDA approval · 2019-10-01FDA Approved: MAXALT — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for MAXALT (rizatriptan benzoate) submitted by Organon LLC.
-
FDA approval · 2019-10-01FDA Approved: MAXALT-MLT — Supplemental Application (Organon LLC)
FDA approves a supplemental application for MAXALT-MLT (rizatriptan benzoate) from Organon LLC.
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ibuprofen from Chartwell RX, LLC under ANDA 202413, authorizing the specified changes to thi…
-
FDA approval · 2019-07-22FDA Approved: TREXIMET — Supplemental Application (Currax Pharmaceuticals LLC)
FDA approves a supplemental application for TREXIMET (sumatriptan succinate and naproxen sodium) submitted by Currax Pharmaceuticals LLC.
-
FDA approval · 2019-06-18FDA Approved: ONZETRA XSAIL — Supplemental Application (Currax Pharmaceuticals LLC)
FDA approved a supplemental application for ONZETRA XSAIL (sumatriptan succinate) by Currax Pharmaceuticals LLC.
-
FDA approval · 2019-06-10FDA Approved: ZEMBRACE SYMTOUCH — Supplemental Application (Upsher-Smith laboratories, LLC)
The FDA approved a supplemental application for Zembrace SymTouch (sumatriptan succinate) from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2019-06-04FDA Approved: EMGALITY — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for EMGALITY (galcanezumab) by Eli Lilly and Company. The approval covers a change to the product's …